The Latest Breaking News from Beam

IN FOCUS: As a musical based on the 2004 Adam Sandler-Drew Barrymore love story prepares for its West End debut, Isabel Dempsey surveys the current deluge of romcom remakes hitting the stage and asks industry folk whether the boom is helping or harming

Google says Deloitte, Salesforce and Duolingo are all interest in Beam (Project Starline), but it won't be for consumers.

Biotech stocks put up a split showing at JPM, where names like BridgeBio, ARS and Harmony stood out with strong preliminary reports.

BEEM stock has underperformed in 2024. Should you bet on a comeback year in 2025?

Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising preclinical BEAM-103 results.

December S&P 500 E-Mini futures (ESZ24) are up +0.21%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.27% this morning as investors braced for the closely contested U.S. presidential election, while also awaiting a new round of economic data and corporate earnings reports.

Magic Notes tool records and analyses face-to-face meetings and suggests follow-up actions

Beam e-scooters sent packing after government ban.

Beam trying to refund customers who have subscriptions.